To improve the website's functionality, we use cookies, including third-party cookies. Read our Privacy Policy for more information
I AgreeAnalysis of Bio Decontamination market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
The global sales of bio decontamination equipment are currently valued at US$ 167 million and are predicted to increase at a CAGR of 4.5% to reach a market size of US$ 208.1 million by 2027.
Demand for bio decontamination services is expected to increase at a CAGR of 5% from 2022 to 2027.
Report Attributes |
Details |
---|---|
Bio Decontamination Market Size (2022E) |
US$ 167 Million |
Forecasted Market Value (2027F) |
US$ 208.1 Million |
Global Market Growth Rate (2022-2027) |
4.5% CAGR |
China Market Growth Rate (2022-2027) |
4% CAGR |
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
According to the intended use of the space, cleanrooms, lab spaces, isolators, and biosafety workstations require a certain level of cleanliness and microbiological control. By using more conventional techniques, such as spraying and swiping an appropriate disinfectant onto a surface, decontamination can be done.
The biosecurity, Life Science, healthcare, experimental, food, IVF, and pharmaceutical industries all heavily rely on bio decontamination systems. One of the most affordable methods of virus decontamination is bio decontamination, resulting in it being frequently favoured over alternative techniques.
Expansion of the bio decontamination industry has been aided by the creation of innovative portable bio contamination equipment. In particular, hydrogen peroxide-based devices are strongly advised due to their material compatibility and safety. The market for bio contamination is expected to expand steadily during the forecast period because of the rise in hospital-acquired diseases and increased public awareness of virus prevention.
According to Fact.MR, a market research and competitive intelligence provider, over the next five years, the global bio decontamination market is expected to expand at a CAGR of 4.5% and reach US$ 208.1 million by 2027.
“Sustained Need in Pharma & Biotech Industries”
Pharmaceutical firms use a wide range of bio decontamination tools, services, supplies, and extras, particularly when making parenteral (injectable) medications.
Demand for cutting-edge facilities outfitted with cutting-edge tools & machines and an effectively decontaminated environment (for effective and efficient manufacturing and research unit) is expected to rise in the coming years due to the rising R&D expenditure and the growing focus on the creation of new therapeutic and diagnosis and treatment products. This is regarded as a promising sign for the expansion of the bio decontamination market throughout the forecast period.
Additionally, the governments of several nations have established strict guidelines for the avoidance of virus contamination. The general tendency of outsourcing bio decontamination services to ensure effective decontamination is another factor supporting the market's expansion.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
“Increased Chances of Acquiring Contagious Diseases in Hospitals”
The COVID-19 pandemic has affected the ways healthcare facilities handle illnesses picked up in hospitals. Nosocomial-acquired illnesses that do not exist or incubate at the time you are admitted to a hospital are known as hospital-acquired infections (HAI).
Hospital infections or toxins are the primary cause of such infections. These infections include pneumonia acquired in hospitals, bloodstream infections linked to central lines, surgical site infections, pneumonia linked to ventilators, urinary tract infections linked to catheters, and infections with Clostridium difficile.
Immunosuppression, old age, prolonged hospital stays, several inherent illnesses, frequent visits to medical facilities, mechanical ventilation assistance, indwelling devices, recent invasive surgeries, and stays in critical care units are risk factors for HAI.
As a result, the elderly population's weakened immune systems are predicted to increase their chances of contracting an infection, increasing the incidence of HAI and driving the growth of the bio decontamination market. HAIs are more likely to occur in people who have several underlying comorbidities, such as blood disorders, diabetes, cancer, and so on.
These individuals drive the market since they often visit hospitals and have increased infection risks. Demand for bio decontamination systems is therefore anticipated to have significant growth over the coming years as a result of the aforementioned factors.
“Budgetary Limitations of Healthcare Facilities & High Use of Manual Bio Decontamination Techniques”
Spraying, manually washing with formaldehyde or bleach, and wiping with an appropriate agent are a few of the usual manual bio decontamination techniques. Due to their cost savings, these technologies are still employed in several developing nations despite their drawbacks, such as difficulties with residual removal and issues guaranteeing coverage over the full area.
Furthermore, healthcare facilities and hospitals in some poor and underdeveloped nations still place less priority on bio decontamination since these nations place more emphasis on capital investments in medical equipment manufacturing and facility expansion. This is one of the primary aspects preventing the bio decontamination business in these nations from expanding.
“North American Governments Making High Investments in Healthcare Facilities”
Due to its strict standards governing patient safety, North America has a firm hold in the bio decontamination business. Expansion of the bio decontamination market in the region will also be aided by the increasing awareness campaigns that are being run about the benefits and necessity of bio decontamination.
Market growth is also anticipated to be aided by North America's robust healthcare sector expansion, rising hospital-acquired infection rates in the region, increasing geriatric population, increased government initiatives, and investments in healthcare facilities' hygiene.
During the forecast period, the Asia Pacific market is anticipated to increase at a promising rate. The Asia Pacific is expected to experience considerable growth in the bio decontamination market because of the rise in government support for healthcare infrastructure.
It is one of the top regions for exporters of pharmaceutical products, which gives a profitable opportunity for the industry's expansion. The region's bio decontamination market is also expected to rise in the next 5 years due to the advanced proliferation of hospitals and clinics.
“Need to Bring Down Rising Cases of Hospital-acquired Diseases”
This statistic emphasizes the need for patient care practices to be improved in the nation's healthcare facilities. As a result, the prevalence of hospital-acquired diseases in the nation drives the demand for good hygiene maintenance, including regular hospital bed sheets and curtains replacement.
Given that frequent hospital admissions and prolonged hospital stays are anticipated to raise the prevalence of hospital-acquired infections. Since longer stays raise the risk of contracting infections, this is projected to fuel demand for biological decontamination services.
“High Production of Pharmaceutical Products in India, China, & Japan”
By 2027, several countries in the Asia Pacific region are anticipated to emerge as promising markets for bio decontamination due to an increase in pharmaceutical product production and export.
China, Japan, and India are accountable for the lion's share of the market expansion in this region.
Increased development of hospitals and clinics is a result of the government's increasing support for the healthcare infrastructure. Thus, the above-mentioned factors boost sales growth of bio decontamination systems.
“Rising Cases of Nosocomial Infections Encouraging Strict Hospital Hygiene Care Management”
The market is anticipated to increase in the coming years due to factors such as rising nosocomial infections, these infections are commonly caused due to long hospital stays and are also known as hospital-acquired or healthcare-associated infections.
As a result, over the projected period, the high incidence and mortality rates linked to hospital-acquired infections are anticipated to fuel market expansion.
Therefore, a high prevalence of these illnesses is driving demand for effective hospital hygiene management, which is driving the target market growth in parallel.
The report discusses key developments in the bio decontamination industry as well as the inorganic and organic growth tactics resorted to by market players. Most companies are emphasizing organic growth strategies such as new product launches, product approvals, and acquiring patents and copyrights.
Mergers, alliances, and partnerships were examples of inorganic growth strategies that were observed in the market. These steps have made it possible for market participants to increase their customer base and revenue share.
With the growing demand for bio decontamination products and services in the worldwide market, market players can anticipate lucrative opportunities in the bio decontamination market over the coming years.
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunities
Buy NowGet A Special pricing for start-ups and universities
Enquiry Before Buying- Humble, Yet Honored -
- Related Reports -
Sales of bio decontamination services are expected to increase at 4.5% CAGR from 2022 to 2027.
The global bio decontamination market currently accounts for a valuation of US$ 167 million.
The global market for bio decontamination is projected to reach US$ 208.1 million by 2027.
The market for bio decontamination equipment in China is expected to expand at 4% CAGR.
Cherwell Laboratories, Fedegari Autoclavi S.p.A., JCE Biotechnology, STERIS PLC, Howorth Air Technology Limited, and TOMI Environmental Solutions, Inc are major companies in the bio decontamination market.